论文部分内容阅读
目的评价阿奇霉素治疗支原体肺炎的临床疗效和不良反应。方法治疗组予阿奇霉素静滴、对照组予红霉素静滴,比较两组治疗的疗效与不良反应。结果两组有效率无显著性差异(P>0.05);治疗组较对照组不良反应少,能明显降低患者胃肠道反应(P<0.01)和局部静脉疼痛(P<0.01)。结论阿奇霉素治疗支原体肺炎疗效好,不良反应少,值得临床广泛运用。
Objective To evaluate the clinical efficacy and adverse reactions of azithromycin in the treatment of mycoplasma pneumonia. Methods The patients in the treatment group received intravenous infusion of azithromycin and the control group received intravenous infusion of erythromycin. The curative effect and adverse reactions of the two groups were compared. Results There was no significant difference between the two groups (P> 0.05). The treatment group had less side effects than the control group, which could significantly reduce the gastrointestinal reaction (P <0.01) and local venous pain (P <0.01). Conclusion Azithromycin treatment of mycoplasma pneumonia is effective, with fewer adverse reactions, it is widely used in clinical.